s-trioxane has been researched along with Malaria in 1 studies
*Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, W; Chen, X; Liu, JO; Posner, GH; Shapiro, TA; Woodard, LE | 1 |
1 other study(ies) available for s-trioxane and Malaria
| Article | Year |
|---|---|
Malaria-infected mice live until at least day 30 after a new monomeric trioxane combined with mefloquine are administered together in a single low oral dose.
Topics: Administration, Oral; Amides; Animals; Antimalarials; Dimerization; Drug Combinations; Heterocyclic Compounds; Malaria; Male; Mefloquine; Mice; Mice, Inbred C57BL; Survival Analysis; Time Factors | 2009 |